medline.ch Onkologie Gynäkologische Tumoren

	Cellular senescence and polycystic ovary syndrome: mechanisms and therapeutic strategies from a new perspective. Ann Med Xin X, Dong L, Li J, Zhang J, Wu H. PMID: 41388677 [PubMed - indexed for MEDLINE]
	Metformin and its derivatives in breast cancer: from glycaemic control to tumor-intrinsic pathways. Breast Cancer Res Alim R, Akalanka HMK. PMID: 41388552 [PubMed - as supplied by publisher]
	Factors Contributing to Late Breast Cancer Diagnosis: A Qualitative Study on the Patient's Perspective in Tanzania. BMC Womens Health Msoka EF, Abraham M, Cyril PM, Serventi F, Kavishe AA, Kitali BM, Saria VF, Bright FB, Henke O, Masenga GG, Mulder BC, Blanchard C, Joffe M, Kantelhardt EJ, Gutnik L, Mmbaga BT. PMID: 41388529 [PubMed - as supplied by publisher]
	Prediction model incorporating dynamic changes in serum tumor markers for evaluating the efficacy of neoadjuvant chemotherapy in patients with breast cancer: a retrospective cohort study. Eur J Med Res Li X, Liu J, Wang Z, Li X, Feng K, Zhang R, He J, Zhang H. PMID: 41388324 [PubMed - indexed for MEDLINE]
	Paraneoplastic cochleovestibulopathy associated with breast cancer: a case report of two patients and literature review. BMC Neurol Yang L, Liu X, Li W, Tang S, Hu Y, Zhang T, Li X, Yue W, Tian S. PMID: 41387816 [PubMed - indexed for MEDLINE]
	Genomic platform specific polygenic risk scores impact breast cancer risk stratification. Commun Med (Lond) Ho PJ, Khng AJ, Tan JHJ, Goy PV, Kamila KA, Li Z, Ho WK, Tan IBH, Chong DQ, Lo E, Goh LL, Wee HL, Hartman M, Dorajoo R, Bertin N, Li J. PMID: 41387625 [PubMed - as supplied by publisher]
	Adherence to Breast Cancer Screening Guidelines Among Age-Eligible US Women: Findings From NHIS 2021. Cancer Med Chandra M, Fokom Domgue J, Yu R, Shete S. PMID: 41387311 [PubMed - indexed for MEDLINE]
	Imaging Surveillance and Risk-Based Management of Known Genetic Mutations in Breast Cancer: A Radiologist's Guide. J Breast Imaging Daraghma M, Alatoum A, Thompson Jacinto BM, Kestelman FP, Fahed RI, Policeni FC, Kim Hsieh SJ. PMID: 41386971 [PubMed - indexed for MEDLINE]
	Perivascular Epithelioid Cell Neoplasm of the Uterus: A Case Report. J Obstet Gynaecol Res Nejkovi, , Doni, Cimbaljevi, Raki. PMID: 41386702 [PubMed - indexed for MEDLINE]
	Performance of an artificial intelligence-based tool for cervical precancer screening in five countries in Africa: a prospective, observational, diagnostic accuracy study. Lancet Glob Health African AVE Collaborative, Barrett C, Joseph JT, Horning MP, Anne M, Banik D, Birhanu F, Burkot S, Chisele S, Chizyuka N, Diallo M, Diop-Ndiaye H, Gaju S, Hu L, Jenison R, Kulhare S, Kuyper S, Laverriere Z, Makwakwa C, Malyangu E, Maparo T, Mukotsanjera C, Shah I, Shibemba AL, Tchereni T, AVE Histopathology Review Group, Hariharan K, Parham G. PMID: 41386246 [PubMed - indexed for MEDLINE]
	Endocrine-based strategies after CDK4/6 inhibitors in biomarker-selected subgroup of hormone receptor positive advanced breast cancer: A systematic review and network meta-analysis. Cancer Treat Rev Escudero A, Bellet M, Saura C, Aguilera A, Papakonstantinou A, Tolosa P, García-Sáenz JÁ, Moreno F, López de Sá A, Schettini F, Seguí E, Gonzalez-Rodriguez M, Navarro V, Ferrero-Cafiero JM, González X, Hernando C, Matikas A, Prat A, Oliveira M, Pascual T, Villacampa G. PMID: 41385990 [PubMed - as supplied by publisher]
	Immunotherapy in the treatment of breast cancer. Magy Onkol Borbála S, Lajos P. PMID: 41385765 [PubMed - indexed for MEDLINE]
	Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026). J Clin Oncol Slomovitz BM, Weroha SJ, Deng W, Chon HS, Podder V, Jenkins Vogel MT, Backes F, Thomas ED, Chen LM, Tenney ME, Westin SN, Markham MJ, Miller DS, Edelson MI, Muller CY, Callahan MJ, Holman LL, Liu JR, Teplinsky E, Kamat A, Guy M, Chern JY, Lea J, Murphy M, Choong GM, Moore ED, Alvarez EA, Rodgers WH, O'Malley DM, Copeland LJ, Herzog TJ, Coleman RL, Gershenson DM. PMID: 41385758 [PubMed - as supplied by publisher]
	Germline Pathogenic Variants Among Women Without a History of Breast Cancer: A Secondary Analysis of the WISDOM Randomized Clinical Trial. JAMA Intern Med Fergus KB, Ross KS, Scheuner MT, Blanco AM, Tice JA, Ziv E, Shieh Y, van 't Veer L, Olopade OI, Goodman DL, Tong BS, Harvey H, DeRosa D, Risty L, Silver E, Kaster A, Fiscalini AS, Blum K, Heise R, Sabacan L, Heditsian D, Brain S, Petruse A, Eklund M, Hiatt RA, Borowsky AD, Naeim A, Park HL, LaCroix AZ, Parker BA, Lancaster R, Esserman J, Wenger N, Arasu V, Anton-Culver H, Esserman LJ, Madlensky L. PMID: 41385723 [PubMed - as supplied by publisher]
	Neoadjuvant Abemaciclib plus Letrozole vs. Chemotherapy in patients with HR+/HER2- Highly Proliferative Breast Cancer. Clin Cancer Res Martín M, Guerrero-Zotano AL, Pérez-López ME, Ruiz-Borrego M, Martinez Jañez N, Chacón JI, Gil-Gil M, Andrés R, Bermejo B, Sánchez-Rovira P, Del Barco S, Ponce JJ, Fernandez I, Martínez de Dueñas E, Hinojo-Gonzále C, González M, García-Garre E, Hernando B, de la Haba-Rodriguez J, Álvarez IM, González-Santiago S, Garcia-Saenz JA, Santaballa A, Casas M, Bezares S, Caballero R, Rojo F, Alba E. PMID: 41385615 [PubMed - as supplied by publisher]
	"This needs to be told to everyone": Content analysis of written immediate responses from an online experiment examining health warning messages about alcohol consumption and breast cancer risk. PLoS One Anbari A, Massey Z, Adediran A, Wang N, Lawrie L, Martinez P, McCarthy D. PMID: 41385524 [PubMed - indexed for MEDLINE]
	Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial. JAMA Esserman LJ, Fiscalini AS, Naeim A, Van't Veer LJ, Kaster A, Scheuner MT, LaCroix AZ, Borowsky AD, Anton-Culver H, Olopade OI, Esserman J, Lancaster R, Madlensky L, Blanco AM, Ross KS, Goodman DL, Tong BS, Hogarth M, Heditsian D, Brain S, Lee V, Blum K, Kim MO, Sabacan LP, Fergus KB, Yau C, Park HL, Parker BA, Kaplan C, Rhoads KF, Eder S, Adduci K, Matthews JB, Wenger NS, Shieh Y, Hiatt RA, Ziv E, Tice JA, Eklund M. PMID: 41385349 [PubMed - as supplied by publisher]
	Disparities in delays and outcomes in patients with HER2-positive breast cancer. Breast Cancer Res Treat Wooster M, DeStephano D, Beauchemin M, Wang S, Wright JD, Hur C, Hershman DL, Accordino MK. PMID: 41385136 [PubMed - indexed for MEDLINE]
	Exploring the effect of Duffy status on patients with breast cancer receiving cyclin-dependent kinase 4/6 inhibitors. Breast Cancer Res Treat Ferri GM, Martinez CB, Acevedo J, Bhatt S, Verma KP, Lee J, Abdallah M, Szalat RE, Sloan JM. PMID: 41385110 [PubMed - indexed for MEDLINE]
	Efficacy and safety of abemaciclib plus endocrine therapy versus endocrine therapy alone in HRâ€‰+â€‰and HER2-negative breast cancer; a systematic review and meta-analysis. Breast Cancer Res Treat Sadia K, Talia T, Hussain I, Chaudhry M, Shahid N, Javaid MK, Kamil MF, Chaudry HZ, Azhar L, Khan HA, Ejaz A, Akram MU, Mahmood S, Abdul Qadeer M. PMID: 41385109 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 321636

Seite 1 von 16082

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung